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The effects of a fermentation filtrate of Ganoderma lucidum (FGL) on carbon tetrachloride (CCl4)-induced
hepatic fibrosis were investigated in rats. Male Sprague-Dawley rats were orally administered with FGL
(20 or 100 mg/kg) for 33 days, and orally administered with CCl4 (1.0 mL/kg; 2 mL/kg of 50% in corn oil)
at 3-day intervals 1 h after FGL treatment. Body and liver weights, blood and histopathological findings in
accordance with hydroxyproline concentrations were analyzed. Chronic exposure to CCl4 reduced the
body weight gain, but increased liver weights and fibrosis, resulting in 3.35-fold increase in hydroxyproline
level. Although FGL did not significantly reduce the CCl4-induced body and liver weight changes, it
attenuated the increases in the hepatic fibrosis and hydroxyproline contents. Taken together, it is
suggested that FGL might prevent hepatic fibrosis, and that FGL or its ingredient could be a potential
candidate for the prevention of chronic hepatic disorders.
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Hepatitis, a high incidence ailment in modern societies,
is caused by hepatitis viruses, chronic alcohol intake, lipid
peroxidative products and various drugs [1]. Chronic liver
injury results in hepatic fibrosis and end stage cirrhosis. This
is one of the major public health problems, related to life-
threatening complications of portal hypertension, liver failure
and finally increased incidence of hepatocellular carcinoma [2].
The relationship between oxidative damage and hepatocellular
injury was observed in many previous studies showing strong
hepatoprotective activities of antioxidative Oriental traditional
herbs, such as Scutellaria radix [1], Ginkgo biloba [3] and
Ganoderma lucidum (GL) [4]. GL, a traditional Oriental
medicinal mushroom, has been widely used for the treatment
of chronic hepatopathy of various etiologies with little or no
side effects [5]. Polysaccharide and triterpenoid components
in GL have been proposed as the bioactive constituents
responsible for the protective activities against toxin- and
ethanol-induced liver injuries [5,6]. It was also reported that
triterpenoids and peptides isolated from GL protect against
carbon tetrachloride (CCl4)- and D-galactosamine-induced
hepatic injuries through its antioxidative and free radical-
scavenging abilities [7-9]. In addition, we showed that culture
extract of GL exerted anti-allergic and anti-atopic effects
[10,11].
Notably, it is well known that fermentation of natural
products leads to increases in active ingredients and to
production of novel compounds. Based on the antioxidative,
anti-inflammatory and anti-allergic, and acute hepatoprotective
activities of GL, a fermentation filtrate of Ganoderma lucidum
(FGL) was expected to improve chronic active hepatic fibrosis.
In the present study, we investigate the antifibrotic effects
of FGL in CCl4-induced chronic hepatic fibrosis model.
Dried GL was minced, macerated, and adjusted to 25-
30% precipitates by adding purified water. Into the
homogenate, cultivated Saccharomyces (strain HM 2104) was
added up to 4% and fermented at 45
oC and pH 5.5 for
30-40 h. The crude culture precipitates were removed by
centrifugation and microfiltration (pore size, 0.05 µm), and
the alcohol produced during fermentation was fully removed
in a vacuum evaporator [12].
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Seven-week-old male Sprague-Dawley rats were orally
administered with FGL (20 or 100 mg/kg) for 33 days, and,
1 h later, orally administered with CCl4 at a dose of 1.0 mL/
kg (50% in corn oil, 2 mL/kg) at 3-day intervals [13]. Body
weights were recorded throughout the experimental period,
and twenty four h after the final treatment, liver weights were
measured. Liver tissues were fixed in 10% formalin, and
paraffin-embedded sections (4 µm) were stained with
hematoxylin-eosin for microscopic examination.
A part of liver tissue was homogenized in a 6 N HCl solution
to make 3% homogenate, and boiled at 120
oC for 20 min
[14,15]. Into an aliquot (50 µL) of the homogenate,
chloramine-T solution (400 µL) was added and incubated for
25 min at room temperature. Again, Ehrlich’s solution (500
µL) was added, incubated in a 65
oC water bath for 20 min,
and the absorbance was read at 550 nm [13].
Data were expressed as the mean±SEM. Statistical analysis
was performed using an analysis of variance (ANOVA) with
the aid of SPSS for Windows v.10.0 (Chicago, Illinois, USA).
A P value <0.05 was considered statistically significant.
CCl4 (1.0 mL/kg) treatment at 3-day intervals decreased
the body weight gain by 12%, which was attenuated by
treatment with FGL in a dose-dependent manner (Figure 1).
Especially, daily treatment with a high dose (100 mg/kg) of
FGL recovered the CCl4-induced decrease in the body weight
gain by 70%. In contrast to the decrease in the body weight
gain, CCl4 not only increased liver weight by 24%, but also
enhanced the hydroxyproline contents to 3.35 folds control
level (Table 1). The increased hydroxyproline content was
confirmed by microscopic findings, exhibiting severe fibrosis
(Figure 2). The liver weights increased by exposure to CCl4
were attenuated by FGL in a dose-dependent manner,
especially to the near-normal level in a high dose (100 mg/
kg). Notably, the increased hydroxyproline contents were
significantly recovered by FGL, in accordance with the
microscopic observations.
In spite of tremendous strides in the modern medicine,
there are not much drugs available for the treatment of liver
disorders [16]. Liver fibrosis results from the fibrogenic
activation of fibrocytes and hepatic stellate cells, called Ito
cells, following continuous hepatocytic injury and cholestasis,
sometimes leading to liver cirrhosis and hepatocellular
carconoma [2,17-19]. In the present study, repeated
administration of CCl4 also induced serious hepatic fibrosis,
in parallel with the increased hydroxyproline contents [13].
Since oxidative stress is one of the most-causative factors
Figure 1. Change in body weights of rats administered with
carbon tetrachloride (CCl4; 1 mL/kg) for 33 days at 3-day
intervals and/or a fermentation filtrate of Ganoderma lucidum
(FGL; 20 or 100 mg/kg daily). ○, normal; ●, CCl4 alone; ▼,
CCl4+20 mg/kg FGL; ■, CCl4+100 mg/kg FGL.
Figure 2. Representative hepatic fibrosis of the liver of rats
administered with carbon tetrachloride (CCl4, 1 mL/kg) for 33
days at 3-day intervals and/or a fermentation filtrate of
Ganoderma lucidum (FGL; 20 or 100 mg/kg daily). A, normal;
B, CCl4 alone; C, CCl4+20 mg/kg FGL; D, CCl4+100 mg/kg
FGL.
Table 1. Effect of a fermentation filtrate of Ganoderma lucidum
(FGL) on the liver weights and hepatic fibrosis induced by
treatment with carbon tetrachloride (CCl4, 1 mL/kg) for 33 days
at 3-day intervals
Treatment
(mg/kg)
Absolute liver 
weight
(g)
Relative liver 
weight
(%)
Hydroxyproline
(µg/kg)
Normal 11.22±1.07 2.66±0.22 07.32±2.02
CCl4 alone 13.86±1.42* 3.72±0.38* 24.55±5.15*
+FGL (20) 13.12±1.34 3.37±0.44 17.36±4.21
#
+FGL (100) 11.65±0.84
# 2.87±0.19
# 11.02±2.13
#
*Significantly different from normal control (P<0.05). 
#Significantly
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of tissue fibrosis, the antifibrogenic effect of FGL was expected.
Moreover, such effects also were inferred from that
polysaccharides, triterpenoids and peptides of GL exerted
protective effects against acute hepatic injury induced by
toxins, CCl4 or D-galactosamine [5,7-9]. More recently, it was
demonstrated that an ethanol extract of GL suppressed
thioacetamide-induced hepatic fibrosis by enhancing
collagenase activity [20].
In the present preliminary study, FGL was confirmed to
possess strong anti-fibrogenic activity. Although active
ingredients and the action mechanisms remain to be clarified,
it is suggested that FGL could be a potential candidate for
the improvement of chronic hepatic disorders.
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